1 / 19

Heart Failure—the Next Frontier

Explore the clinical and economic burden of heart failure and the importance of prevention and management programs. Learn about evidence-based guideline recommendations and how they align with the Right Care Initiative mission.

mobleyg
Download Presentation

Heart Failure—the Next Frontier

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Heart Failure—the Next Frontier Carol Zaher, MD, MBA, MPH Medical Director Health Net June 21, 2018

  2. Disclosure • I do not have relevant financial relationships with commercial interests.

  3. Objectives • Summarize the clinical and economic burden and importance of heart failure to the health care system • Provide an overview of current evidence-based guideline recommendations for treatment of heart failure • Substantiate the rationale for why inclusion of a heart failure prevention and management program aligns with the Right Care Initiative mission

  4. Overview • Types of HF • Heart failure statistics • US • CA • Burden of disease • Disease management efforts • Treatment options • EB Guidelines • Role for RCI?

  5. Heart Failure Basics Types What’s the difference? • HFrEF • HFpEF • HFiEF • Underlying pathology • Outcomes similar • Treatment?

  6. HF Stats

  7. HF Statistics* • ARIC study of the NHLBI: 1.0 million new HF cases annually • 6.5 million American adults ≥20 years of age had HF between 2011 and 2014 compared with 5.7 million between 2009 and 2012. • Prevalence of HF will increase 46% from 2012 to 2030, resulting in >8 million people ≥18 y0 • Increasing incidence and improved survival contribute to increasing prevalence • African Americans had the highest risk of developing HF, followed by Hispanic, White, and Chinese Americans (4.6, 3.5, 2.4, and 1.0 per 1000 person-years, respectively). • 30-day, 1-year, and 5-year case fatality rates after hospitalization for HF were 10.4%, 22%, and 42.3%, respectively • Most common risk factors for HF: CAD, HTN, DM, obesity, smoking *Heart Disease and Stroke Statistics— 2018 Update A Report From the American Heart Association March 20, 2018 Circulation. 2018;137:e67–e492. DOI: 10.1161/CIR.0000000000000558

  8. Burden of Disease-US • Discharges for HF decreased from 2004 to 2014, with principal diagnosis discharges of 1,042,000 and 900,000, respectively • In 2014, there were 2,371,000 physician office visits with a primary diagnosis of HF and 459,000 ED visits** • *CDC; 2010 National Ambulatory Medical Care Survey and 2010 National Hospital Ambulatory Medical Care Survey. http://www.cdc.gov/nchs/ahcd/ahcd_questionnaires.htm.Accessed July 17, 2013. • **NAMCS, NHLBI unpublished tabulation • Age-adjusted 28-day and 1-year mortality after hospitalization was 10.4% and 29.5%, respectively. • In one study, 43% HF pts are hospitalized at least 4 times. More than one half of all hospitalizations were related to non-cardiovascular causes*** • ***J Am Coll Cardiol. 2009;54:1695–1702. doi: 10.1016/j. jacc.2009.08.019.

  9. Cost of HF- US • Total estimated cost for HF ~$30.7 billion in 2012(2010$)* • 68% direct medical costs • Hospital costs represent majority • By 2030, HF total cost will increase to almost $70 billion *American Heart Association. Circ Heart Fail. 2013;6:606–619. doi: 10.1161/HHF.0b013e318291329a

  10. HF Prevalence CA Age > 65 yrs* *Conroy SM, Darsie B, Ilango S, Bates JH (2016). Burden of Cardiovascular Disease in California. Sacramento, California: Chronic Disease Control Branch, California Department of Public Health.

  11. HF Burden in California* *Conroy SM, Darsie B, Ilango S, Bates JH (2016). Burden of Cardiovascular Disease in California. Sacramento, California: Chronic Disease Control Branch, California Department of Public Health.

  12. HF Mortality CA* *Conroy SM, Darsie B, Ilango S, Bates JH (2016). Burden of Cardiovascular Disease in California. Sacramento, California: Chronic Disease Control Branch, California Department of Public Health.

  13. Evolution of Disease Management for HF

  14. Attempts at Disease Management for HF Early efforts • HEDIS measures • LV EF measurement • Use of ACEI • Creation of DM /Case Management programs to integrate care • Initial focus on post DC • Later on high risk HF pts • Emergence of care in an Observation Unit-CMS developed new coding for such outpatient care • Heart failure clinics/specialists • Guideline, Care Maps, and Best Practice development • Remote care • Home scales • Telemedicine • Team approach: pharmacists, MD, NP, social services, etc.

  15. Get With the Guidelines • American Heart Association collaborative quality improvement program • Goal is to improved adherence to evidence based care in pts hospitalized for heart failure • Voluntary observational program • Registry data • Patient Management ToolTM • Decision support • Real-time benchmarking

  16. Get With the Guidelines-Heart Failure

  17. HF as Part of the Right Care Initiative? • HF imposes a steep economic and clinical burden on the health care system and patient QOL • Multiple treatments available for HF make optimal management more complex

  18. HF as Part of RCI ! • Primary prevention of HF can be augmented by greater adherence to the AHA’s Life Simple 7 goals: non-smoking, optimal body mass index, physical activity, diet, and control of cholesterol, blood pressure, and glucose.* • Current RCI efforts toward reducing heart attacks, stroke and improving diabetic care/outcomes • HFs top underlying pathologies are MI, HTN, and diabetes • RCI efforts to reduce incidence of MI, treat HTN and treat DM aligns with methods to prevent HF. *Heart Disease and Stroke Statistics— 2018 Update A Report From the American Heart Association March 20, 2018 Circulation. 2018;137:e67–e492. DOI: 10.1161/CIR.0000000000000558 Folsom et al. Am J Med 2015;128:970-6

  19. Thank You! • Carol Zaher, MD, MBA, MPH • carol.a.zaher@healthnet.com

More Related